Medical Research Excellence

Research funding at the Larner College of Medicine has increased 300 percent in the last decade, to more than $82 million annually. Today, researchers in laboratory, clinical and community settings work to bring greater understanding of disease and wellness, and new, more effective treatments in key areas such as:

  • Cancer Research
  • Cardiovascular Research
  • Health Services Research and Education, Outcomes Research, and Quality Improvement
  • Immunobiology & Infectious Disease Research
  • Metabolic Research
  • Neuroscience Research
  • Pulmonary Research

Learn more about our research programs >>


Meet our Scientists

rosscolgate150x150Meet a Scientist: E. Ross Colgate, M.P.H.

UVM Vaccine Testing Center researcher E. Ross Colgate, M.P.H., spent two years working in Bangladesh trying to understand why a rotavirus vaccine that prevents the majority of cases in the U.S. works only 40 to 60 percent of the time in Bangladeshi infants. 
Read more >>

NEW! Internal Funding Opportunities

A new pilot research funding opportunity targeting health services research is now available, with a maximum of two $50,000 grants awarded. The application deadline is May 1, 2017. 
LEARN MORE >> 


Recent News


Buskiewicz's Study Reveals Potential Key to Alternative Lupus Treatment

20161011_Pathology_Laboratory_Medicine-009Only one new drug has become available over the past 50 years for the estimated 1.5 million Americans and five million-plus people worldwide suffering from lupus, but new research has identified a previously unknown mechanism involved in the immune response that could provide an alternative therapy target. Read more >>


Research Spotlight

  • American Heart Month: Zakai Research Q&A on Populations Most at Risk for Vascular Disease
    February 3, 2017
    The following interview with Neil Zakai, M.D., M.Sc., associate professor of medicine at the Larner College of Medicine at the University of Vermont, originally appeared on the Facebook page of the Thrombosis and Haemostasis journal and focused on his research publication, titled “D-dimer and the Risk of Stroke and Coronary Heart Disease: The REasons for Geographic and Racial Differences in Stroke (REGARDS),” which was pre-published online in December 2016. (Key: TH = Thrombosis and Haemostasis; NZ = Neil Zakai)
  • Littenberg & Chopan’s Study Finds Association between Eating Hot Peppers and Decreased Mortality
    January 19, 2017
    Like spicy food? If so, you might live longer, say researchers at the Larner College of Medicine at the University of Vermont, who found that consumption of hot red chili peppers is associated with a 13 percent reduction in total mortality – primarily in deaths due to heart disease or stroke – in a large prospective study.